USSTOCK.TODAY
Market Closed Log in Sign up

Bristol Myers Squibb Growth Portfolio Revenue Reaches $7.7 Billion

The Motley Fool +1 · ·by G4L

BMY Bristol-Myers Squibb Co
$58.80 +0.79%
View chart & analysis →
  1. 1Bristol Myers Squibb recorded $7.7 billion in growth portfolio revenue for a single quarter.
  2. 2As of the third quarter, the growth portfolio accounts for approximately 60% of Bristol Myers Squibb's total drug sales.
  3. 3Eliquis is expected to face generic competition starting around 2028.

So what's the key point?

Bristol Myers Squibb's growing drug revenue reached $7.7 billion. It is important to note that Eliquis will face competition from generic drugs starting around 2028.

Source The Motley Fool +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →